{"name":"Wave Life Sciences Ltd.","slug":"wave-life-sciences-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"WVE-007","genericName":"WVE-007","slug":"wve-007","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"WVE-007","genericName":"WVE-007","slug":"wve-007","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE1jYWo0QzlFd1kwNVQ5ekd6aHBjS0ZVZmVWOUVNZmxXZlFscDFLQVd5LWdSMVhNWjhYMVBpMkFwRnl2X0dnODZKTkhhcmxyUlNL?oc=5","date":"2026-04-04","type":"pipeline","source":"sg.finance.yahoo.com","summary":"Wave Life Sciences Ltd. (WVE) stock price, news, quote and history - sg.finance.yahoo.com","headline":"Wave Life Sciences Ltd. (WVE) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxNa2c5RWVob0UwcGplR2dISkJpNldIUlJNdDRxRVU3aWdFNU4wcFVXcGd0SUVGa2QxdGJfdzNkbmp1Nlk5aVNZWlBWZE9MalY5UXhiaHFFTHljblpNMGdSejd5SUhSaFNTYjRqSVVaems0S3N6TU5jZ0pFWjFrcHBJbE5RbGtDUzBnaEZGeWN5Z1Q5MFlXRkNacDMwUV9tTVNPUnM3a21SRlFsajJaUVp6OFhwMWFrRWdWTFZDQlR2U2E4V01XLVhZVnZhd2tmeUp6QWZjdkh2azZodk9EdktCR1VVUWJFa0hLSU1OVG1TdWJxZHBaTWhNN2o1VF8yYjBCV2VuQWpXOGQ?oc=5","date":"2026-03-31","type":"pipeline","source":"Benzinga","summary":"Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving High - Benzinga","headline":"Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving High","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-27","type":"trial","source":"medicaldialogues.in","summary":"Setback to Wave Life Sciences: Obesity Drug WVE-007 Shows Limited Efficacy in Early Trial - medicaldialogues.in","headline":"Setback to Wave Life Sciences: Obesity Drug WVE-007 Shows Limited Efficacy in Early Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxQNnFQWnE2aFlNemhiSWNpcWo5Y2ZYV3NKWVVEbGRoNXo5ZmFyY05UanRUV1JoUlp6emJ5bGNacXBKbGI3Ri1ab1g4NnNtdGRlTG5XelNueEZKVFhMODFnWkx3VDVYTGEyQ09aZ0dOdnBMZHFaV0xHaURGUUNJaUdzdWxOM1hBSzNpOFY0b2piT21nZGJYSlIwRWVVM0pRUlNxRjNkT05CVThXaEhFcjhtcU5FYzZCZzNkZ3VaMlRySmNMOHVKeEY0RGtaTDd6TjZqWWc?oc=5","date":"2026-02-19","type":"pipeline","source":"Investing News Network","summary":"Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development - Investing News Network","headline":"Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE5DQXdfZXJJWWJaNGcydk9wTXhERGp4WGNmSDB0Y1V2a0NIQV9HU2hEN3Nrc0k0OTJpem16QkNBVUY5alBRdjAxZE1KTGFZaC1XRnFDVndFWWR3NUVvMFRVTzJocnhyYnJ0bm1EOFBtNA?oc=5","date":"2026-02-03","type":"pipeline","source":"pharmaphorum","summary":"GSK departs Wave's AATD programme - pharmaphorum","headline":"GSK departs Wave's AATD programme","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPLUFQTVdpYTJvZTlJZDZKQmlWa3N1RnVzZkJMUjhyTkZYaVhlNVN0TlRxdGhWZUc5cjhHLXpIcUFPY3JZdFpkcnNvWlBvYlgxMnRmczNZRGJvMG1iZVJFUHh6RWJKdk9pSDVyOF84aGJVcUxweXdTR1l6MXZNeVU2Q05XNHNicWJGdW5KMjU4ZGxXT2pXakhn?oc=5","date":"2026-02-03","type":"pipeline","source":"The Pharma Letter","summary":"Wave regains WVE-006 rights, speeds AATD strategy - The Pharma Letter","headline":"Wave regains WVE-006 rights, speeds AATD strategy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQdXJSakR6VTlpYXowSXFTdk9sNjI1ZDlvbTZxUGpTQUdwbk12RFVvRTJRaDZ5NW9GVzdtcUxfR042NlFQNEhXT01SNDliWG9Db0VzN3B0cGl5MHdRVmM1TnRPR25jb1RDelZOd1VBck9QdkpQZV9PVThiM1M2ZDNEeTZlYXpQXzkyeXZF?oc=5","date":"2026-02-02","type":"pipeline","source":"BioPharma Dive","summary":"GSK walks away from pioneering Wave RNA editing drug - BioPharma Dive","headline":"GSK walks away from pioneering Wave RNA editing drug","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-16","type":"pipeline","source":"simplywall.st","summary":"Subdued Growth No Barrier To Wave Life Sciences Ltd. (NASDAQ:WVE) With Shares Advancing 128% - simplywall.st","headline":"Subdued Growth No Barrier To Wave Life Sciences Ltd. (NASDAQ:WVE) With Shares Advancing 128%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOamVDZTh0T2VZT3dtTVo0cWNSTDNXNHZPNUFVTzBJalBMOFdEVXJnMkwyTFZieEU3bGU3bjZPQnZnRXRUdXYtNW42OFRpeGpZZjhxbVd3TzhFMXl0aGczUW5PcXAtZVNZWGdmbkhrdGctZUVuWDVsa0VnTGZWejZBUnpNMUp1NnVKbG1BM0ZyRndKdw?oc=5","date":"2025-12-08","type":"pipeline","source":"Finviz","summary":"Why Wave Life Sciences Stock Vaulted 146% Higher on Monday - Finviz","headline":"Why Wave Life Sciences Stock Vaulted 146% Higher on Monday","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE1NeHB6NFpvb0NvTHMwbjF5cnlTTFN4RmlITi1PeXFJM292ZWNRMTlKazJ3Sk41QUowS0hpUEswMU1UbGxVRk1MZWMxc21KR3BSd2hXdEZ5OEJhYXM?oc=5","date":"2025-12-08","type":"trial","source":"Finimize","summary":"Wave Life Sciences Rides Positive Data To Big Stock Gains - Finimize","headline":"Wave Life Sciences Rides Positive Data To Big Stock Gains","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQS1VHdUdiMXFwWk5PU1NJc2k3dE9JeU84MmtYMlpONE9udUhzTEZLQ29iS2pEcm5Nbkw4bkhnclFhUXdrWFJ5ZURCX3FOdUg3dWxYNFBiRTg1eUxoUFhHTF9xVTEzYnJkV2VFY3pEM25XdlBEQlhteEc2MEhuanlEQll4WV90Z1o0a3ZJYU5XMmRZWXRlMFN5enRDekxwaVpmNUFDTXo2am0?oc=5","date":"2025-12-08","type":"pipeline","source":"BioWorld News","summary":"Wave Life, Structure and Ascletis post wins in obesity management - BioWorld News","headline":"Wave Life, Structure and Ascletis post wins in obesity management","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOWUlPX3hWNUlxaGZpQzV6aFZRNzF4MXBSRl9NdVk1QWVJMTVaM1ltUjJYN2l0MzM0LXpZeXNQOFlNVHBfVXdsaVFVZlZyZHc2Z2w5TF9hQ2ZNeDRBa3E4WGV2bzkzVmtCR0FOdWxJZjFXV1FNWDN0TGRTU1F6TFFLRDdteEQ4OEdJRklGYmFwRktTTkZmQU5CNnpMUm9Lb21LRXhPT1MxYlVRY0k?oc=5","date":"2025-12-05","type":"pipeline","source":"seekingalpha.com","summary":"Wave Life Sciences: Being Realistic, There Is Still So Much To Prove (NASDAQ:WVE) - seekingalpha.com","headline":"Wave Life Sciences: Being Realistic, There Is Still So Much To Prove (NASDAQ:WVE)","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}